Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.
Guo Y, Li Y, Zhao P, Bi J, Gou C, Chuai Z, Yu S, Zhang R, Du J, Ou Y, Xu R, Guo N, Wang F-S, Li Y
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.